Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Pivot Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Target Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Query: EC:3.2.1.17 (
lysozyme
)
21,489
document(s) hit in 31,850,051 MEDLINE articles (0.00 seconds)
Arthrigenicity of Mycobacterium smegmatis subfractions appeared to be remarkably potentiated in oil vehicles such as squalane or mineral oil, while water-in-oil emulsions containing
Arlacel
A appeared to decrease or suppress their arthritogenicity. It seems that
Arlacel
A can exert a suppressive effect on the arthritogenicity of the subfractions. Poly I:C and acetylated wax D potentiated the arthritogenicity of
lysozyme
-solubilized product, while cord factor was unable to do so. When given together with either cell membrane fraction or cell envelope, the
lysozyme
-solubilized product produced much more severe disease than that of
lysozyme
-solubilized product alone. Cell walls lost much of their arthritogenicity when mixed with
lysozyme
-solubilized product.
...
PMID:Arthritogenicity of Mycobacterium smegmatis subfractions, related to different oil vehicle and different composition. 108 57